March 27, 2025 - 08:47

The incoming CEO of JSR, a prominent Japanese chip materials manufacturer, has announced a strategic shift in the company's focus. Tetsuro Hori, set to take over the CEO position on April 1, revealed plans to prioritize restoring the company's financial performance rather than pursuing mergers and acquisitions within the sector.
In a recent interview, Hori acknowledged the current challenges facing JSR, particularly the poor financial results stemming from significant losses in its life sciences division. This downturn has led to speculation in the industry regarding the potential sale of that division. Hori's commitment to stabilizing the company's finances underscores the urgency of addressing these issues before considering any expansion or consolidation strategies.
As JSR navigates these turbulent waters, stakeholders will be closely monitoring the company's performance and Hori's leadership approach in the coming months. The focus on financial recovery signals a cautious but necessary shift in strategy for the company.
August 27, 2026 - 09:43
EverGen Infrastructure Reports Q2 2026 ResultsVANCOUVER - EverGen Infrastructure Corp. has released its financial results for the second quarter of 2026, covering the period ending June 30. The company, which focuses on renewable natural gas...
August 26, 2026 - 19:01
Nutanix Reports Fourth Quarter and Fiscal 2026 Financial ResultsNutanix has reported financial results for its fourth quarter and full fiscal year ending July 31, 2026, highlighting a 16 percent year-over-year increase in annual recurring revenue (ARR). The...
August 26, 2026 - 03:06
The multiplying risks of financing data centresWall Street`s biggest financial institutions are diving headfirst into the data center gold rush, but the euphoria is starting to meet a wall of caution. As the demand for artificial intelligence...
August 25, 2026 - 23:39
Akin, an Elite Global Law FirmDallas - Akin, a global law firm, recently provided legal counsel to Crestline Direct Finance, L.P. in connection with a $50 million senior secured credit facility extended to Kreg Therapeutics LLC...